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Abstract
Leptin is a hormone which is predominantly secreted by adipose tissue. Recent studies have
shown that leptin increases arterial blood pressure. Although data from available animal studies
clearly indicate an association between leptin and hypertension, results of human studies have
been less definitive. We conducted a case-control study to examine the association between serum
leptin levels and hypertension in 111 hypertensive subjects and 222 male controls, using condi-
tional logistic regression analyses. Mean serum leptin levels were found to be marginally higher
in the case subjects than in the control subjects (3.3 ng/ml versus 3.0 ng/ml), however, condi-
tional logistic regression analysis revealed that subjects in the highest quartile had a significantly
increased risk of hypertension compared with those in the lowest quartile, even after adjusting for
drinking status and diabetes mellitus (adjusted OR, 2.11;95% CI, 1.01-4.39). Our findings suggest
that leptin plays an important role in the development of hypertension.
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besity increases the risk of cardiovascular dis-
ease through multiple mechanisms including 
hypertension,  diabetes,  dyslipidemia and atheroscle-
rosis.  Adipose tissue has long been considered passive 
tissue that specializes in energy storage,  but recent 
research has demonstrated that adipose tissue pro-
duces and secretes various bioactive substances,  
which are known as adipocytokines [1,  2].  Leptin is 
an adipocyte-derived hormone that acts in the hypo-
thalamus to regulate appetite and energy expenditure.  
Recent research has found that leptin is a pleiotropic 
hormone with multiple actions that are potentially 
relevant not only to the control of appetite but also to 
cardiovascular function,  insulin secretion,  angiogen-
esis,  immune response and haematopoiesis [3].  
Landsberg et al.  report that hyperinsulinemia and 
insulin resistance are associated with obesity-related 
hypertension and may play a role in the pathogenesis 
of hypertension through their eﬀects on the sympa-
thetic nervous system and kidneys [4].  However,  in 
experimental and clinical studies,  insulin infusion has 
not been shown to cause a hypertensive shift in blood 
pressure [5,  6].  The association between obesity and 
hypertension suggests that the adipose mass may be an 
important tissue in the regulation of blood pressure 
[7].  Considine et al.  report that obese subjects have 
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higher serum leptin levels than normal-weight subjects 
[8,  9].  Additionally,  Aizawa-Abe et al.  found that 
obesity-induced hyperleptinemia may increase sympa-
thetic nerve activity,  contributing to a signiﬁcant 
elevation in blood pressure [10].  Therefore,  it is 
reasonable to examine leptin as a potential link 
between obesity and high blood pressure.  Data from 
animal studies clearly indicate an association between 
leptin and hypertension [7,  10ﾝ13] but the results of 
human studies are less deﬁnitive [14ﾝ17].  Therefore,  
we performed a matched case-control study to evaluate 
whether or not serum leptin levels are associated with 
hypertension.
Materials and Methods
　 Subjects. The subjects of the present study 
were 111 male employees who were participants in 
health insurance society A in Fukuoka Prefecture,  
Japan and who received an annual health check-up in 
2000.  All subjects had hypertension,  which was 
deﬁned as having a systolic blood pressure (SBP) of 
140＋mmHg and/or a diastolic blood pressure (DBP) 
of 90＋mmHg,  and/or being under antihypertensive 
treatment.  The creatinine levels of all study subjects 
were within reference range,  and no subject suﬀered 
secondary hypertension due to endocrine disease.  For 
each case subject,  2 control subjects were randomly 
selected and matched with the case subject for age 
(within±1 year) and body mass index (BMI; within
±1).  The control subjects were normotensive sub-
jects with no history of hypertension.  Informed con-
sent was obtained from each subject.  This study was 
approved by the Ethics Committee of Fukuoka 
University.
　 Measurements. A fasting blood sample was 
drawn from a peripheral vein into a siliconized dispos-
able plastic tube.  Serum samples were kept at －80℃ 
for subsequent assays.  The level of serum leptin was 
evaluated by enzyme immunoassay (Human Leptin RIA 
Kit; Linco Research,  St.  Charles,  MO,  USA).  
Serum total cholesterol (TC) and high-density lipopro-
tein cholesterol (HDL-C) were measured enzymati-
cally using commercial enzyme kits (Wako,  Osaka,  
Japan and Daiichi Kagaku,  Tokyo,  Japan respec-
tively).  Hemoglobin A1c (HbA1c) was measured by 
latex agglutination using a commercially available kit 
(Fuji Rebio,  Tokyo,  Japan).  Uric acid was measured 
by the uricase F-DAOS method using a commercially 
available kit (Wako).  SBP and DBP were measured 
in the daytime (09 : 00ﾝ15 : 00) using a standard mer-
cury sphygmomanometer with the cuﬀ on the right arm 
and the subjects in a sitting position.  When the SBP 
or DBP was≧140 mmHg or≧90 mmHg,  respec-
tively,  it was measured again twice after a rest 
period.  The ﬁrst BP measurement was used as the BP 
value for the purposes of this study.  We deﬁned 
hypercholesterolemia as a TC value of≧240 mg/dl 
and/or the use lipid-lowering agents,  and diabetes 
mellitus as a HbA1c value of≧6.5ｵ and/or treat-
ment for diabetes mellitus with insulin or oral agents.  
BMI,  weight (in kilograms) divided by the square of 
height (in meters),  was used as an index of relative 
weight.  Each subject completed a questionnaire cov-
ering his clinical history,  smoking status and alcohol 
consumption.  The subjects were assigned to 1 of 3 
smoking status groups: current smokers,  ex-smokers 
and never-smokers.  Alcohol intake was likewise clas-
siﬁed into 3 categories: regular drinkers,  ex-drinkers 
and never-drinkers.
　 Statistical analysis. All analyses were con-
ducted using the Statistical Analysis System (SAS,  
Version 9.1; SAS,  Cary,  NC,  USA).  For continu-
ous variables,  results are presented as mean±stan-
dard deviation (SD) or median (interquartile range),  
and diﬀerences between the case and control groups 
were evaluated using an unpaired t test.  Categorical 
variables are presented by frequency counts,  and 
intergroup comparisons were tested for statistical 
signiﬁcance using a χ2 test.  Because the distributions 
of serum leptin and triglyceride levels were skewed,  
log transformation was used,  which yielded more 
normally distributed data.  Associations between 
hypertension and serum leptin levels were analyzed by 
conditional logistic regression analysis.
Results
　 The clinical characteristics of the study subjects 
are presented in Table 1.  Drinking status and diabe-
tes mellitus were found to diﬀer signiﬁcantly between 
case subjects and control subjects (non-drinkers,  8.2
ｵ versus 22.2ｵ; current drinkers,  91.8ｵ versus 
76.0ｵ; ex-drinkers,  0ｵ versus 1.8ｵ; diabetes mel-
litus,  10.8ｵ versus 2.3ｵ).  No diﬀerences were 
found in smoking status or hypercholesterolemia 
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between the 2 groups.  The metabolic characteristics 
of the study subjects are shown in Table 2.  Log-
transformed serum leptin levels and HbA1c were 
marginally higher in the case subjects than in the 
control subjects (log-leptin,  0.5 ng/ml versus 0.4 ng/
ml; HbA1c,  5.1ｵ versus 4.9ｵ),  and HDL-C levels in 
the case subjects were signiﬁcantly higher than in the 
control subjects (63.0 mg/dl versus 57.0 mg/dl).  
There were no signiﬁcant diﬀerences between case 
subjects and control subjects in the levels of log-
171Hyperleptinemia and HypertensionJune 2008
Table 1　 Basic characteristics of the study population
Case subjects Control subjects
Characteristics n n P value
Age (years) 111 49.3 (5.1) 222 48.9 (5.1) 0.59
Smoking status (ｵ)
Non-smokers 59 52.7 133 59.7 0.26
Current smokers 41 37.3 63 28.5
Ex-smokers 11 10.0 26 11.8
Drinking status (ｵ)
Non-drinkers 9 8.2 49 22.2 ＜.001
Current drinkers 102 91.8 169 76.0
Ex-drinkers 0 0.0 4 1.8
Body mass index,  mean (Kg/m2) 111 24.2 (2.8) 222 24.0 (2.6) 0.45
Systolic blood pressure (mmHg) 111 145.8 (12.3) 222 121.5 (10.6) ＜.0001
Diastolic blood pressure (mmHg) 111 92.4 (7.3) 222 75.4 (8.9) ＜.0001
Diabetes mellitus (ｵ) 12 10.8 5 2.3 ＜.001
Hypercholesterolemia (ｵ) 21 18.9 33 14.9 0.34
SD: standard deviation
Data are expressed as mean (SD) or as frequency counts (ｵ) as appropriate.
P-value refers to overall diﬀerences across groups as derived from an unpaired t-test (for continuous variables) or from a χ2 test ( for cate-
gorical variables).
Table 2　 Biochemical characteristics of the study population
Case subjects Control subjects
Characteristics P value
Leptin level (ng/ml)
mean (SD) 3.3 (1.5) 3.0 (1.6)
median (IQR) 2.9 (2.3ﾝ4.3) 2.7 (2.0ﾝ3.7)
Log-leptin level, mean (SD) 0.5 (0.2) 0.4 (0.2) 0.079
Triglyceride (mg/dl), mean (SD) 191.8 (173.4) 185.0 (184.9)
Log-triglyceride, mean (SD) 2.2 (0.3) 2.2 (0.3) 0.88
Cholesterol level (mg/dL), mean (SD)
TC 206.4 (34.1) 201.1 (34.0) 0.18
LDL-C 108.8 (28.8) 110.6 (29.8) 0.61
HDL-C 63.0 (15.0) 57.0 (12.7) ＜0.001
Creatinine (mg/dl), mean (SD) 1.1 (0.1) 1.1 (0.1) 0.49
Uric acid (mg/dl), mean (SD) 5.9 (1.6) 5.9 (1.3) 0.81
HbA1c (ｵ), mean (SD) 5.1 (1.1) 4.9 (0.7) 0.07
TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; HbA1c, hemoglobin 
A1c; SD,  standard deviation; IQR,  interquartile range.
P-value refers to overall diﬀerences across groups as derived from an unpaired t-test (for continuous variables) or from a χ2 test (for cate-
gorical variables).
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transformed triglyceride,  TC,  LDL-C,  creatinine or 
uric acid.
　 Next,  we analyzed the association between serum 
leptin levels and hypertension.  The results of condi-
tional logistic regression analysis are shown in Table 
3.  The case subjects and control subjects were 
grouped into quartiles for serum leptin levels with 
interquartile cut-oﬀ points of 2.1,  2.7 and 3.7 ng/mL.  
Subjects in the highest quartile of serum leptin levels 
had a signiﬁcantly increased risk of hypertension,  
compared with those in the lowest quartile (odds ratio,  
OR,  2.35; 95ｵ conﬁdence interval,  95ｵ CI,  1.15ﾝ
4.81).  Moreover,  high serum leptin levels were sig-
niﬁcantly associated with hypertension even after 
adjustment for drinking status and diabetes mellitus 
(adjusted OR,  2.11; 95ｵ CI,  1.01ﾝ4.39).  These data 
suggest that hyperleptinemia is an independent vari-
able for hypertension.
Discussion
　 The present study has demonstrated that serum 
leptin levels are associated with hypertension.  As 
shown in Table 2,  serum leptin levels were similar in 
normotensive and hypertensive subjects.  However,  
when we performed conditional logistic regression 
analysis to analyze the association between serum 
leptin levels and hypertension,  we found that subjects 
in the highest quartile of serum leptin levels had a 
signiﬁcantly increased risk of hypertension,  compared 
with those in the lowest quartile.  These results sug-
gest that leptin plays an important role in the develop-
ment of hypertension.  Our data are only partly consis-
tent with those recently published by Barba et al.  
[18],  who report that men with higher leptin levels 
have a signiﬁcantly greater probability of being hyper-
tensive,  adjusting for diﬀerences in age,  total adipos-
ity and fat distribution.  In the present study,  no dose-
response relationship was detected.
　 The results of earlier studies on the role of leptin 
in human hypertension are not consistent.  Some epi-
demiological studies report signiﬁcantly higher leptin 
levels in essential hypertensive patients than in con-
trols [19,  20],  or a signiﬁcant correlation between 
leptin levels and blood pressure [16].  Hirose et al.  
note that the correlation of mean blood pressure with 
leptin remains in obese adolescents even after adjust-
ment for age and BMI [17].  However,  these results 
were not conﬁrmed by Kokot et al.  [15] or Uckaya et 
al.  [14].  No association was found between 24-h 
DBP and BMI-adjusted leptin by Narkiewicz et al.  
[21],  while Suter et al.  report a signiﬁcant relation-
ship between SBP and plasma leptin levels in hyper-
tensive women but not in hypertensive men [22].
　 However,  recent studies report that fasting plasma 
leptin levels appear to be related to various cardiovas-
cular diseases including stroke [23] and myocardial 
infarction [24].  Leptin thus seems to play an impor-
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Table 3　 Crude and adjusted odds ratios for hypertension
Case subjects Control subjects Crude Adjusted1
n (ｵ) n (ｵ) Odds Ratio (95ｵ CI) Odds Ratio (95ｵ CI)
Serum leptin level (ng/ml)
0ﾝ2.1 23 (20.7) 63 (28.4) 1 (reference) 1 (reference)
2.2ﾝ2.7 27 (24.3) 53 (23.9) 1.38 (0.72ﾝ2.66) 1.43 (0.73ﾝ2.81)
2.8ﾝ3.7 26 (23.4) 59 (26.6) 1.22 (0.64ﾝ2.35) 1.05 (0.52ﾝ2.10)
3.8＋ 35 (31.5) 47 (21.2) 2.35 (1.15ﾝ4.81) 2.11 (1.01ﾝ4.39)
p for trend　0.14 p for trend　0.15
Drinking status
Non-drinkers 9 ( 8.2) 49 (22.2) 1 (reference) 1 (reference)
Drinkers 102 (91.8) 173 (77.8) 3.14 (1.49ﾝ6.63) 2.78 (1.28ﾝ6.04)
Diabetes mellitus 12 (10.8) 5 ( 2.3) 5.65 (1.81ﾝ17.62) 5.06 (1.58ﾝ16.22)
Data are expressed as odds ratios,  95ｵ conﬁdence interval,  95ｵ CI.
The case subjects were matched with controls for age and BMI.
1Odds ratios were adjusted for drinking status and diabetes mellitus.
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tant role in the development of cardiovascular dis-
eases.  Recently,  the concept of selective leptin 
resistance was proposed,  allowing the hypothesis that 
the sympathoexcitatory actions of leptin are preserved 
despite resistance to its satiety and weight-reducing 
action [25].  If leptin resistance is selective in human 
obesity,  then leptin could contribute to increased 
sympathetic activity and elevated arterial pressure.  
The pathogenesis of essential hypertension remains to 
be clariﬁed.
　 The present study has several limitations.  First,  
unmeasured variables related to blood pressure and/or 
leptin may confound the association between leptin and 
hypertension.  For example,  we were unable to mea-
sure fasting insulin levels in our subjects.  Therefore,  
no statement regarding the interaction between leptin 
and fasting insulin can be made without further study.  
Second,  sampling was performed at diﬀerent times of 
day; a factor which may aﬀect the measurement of 
leptin level since circulating leptin shows a circadian 
rhythm.  Nevertheless,  there is no reason to believe 
that the spread of sampling times diﬀered between the 
case subjects and control subjects.
　 To summarize,  serum leptin levels were margin-
ally higher in case subjects than in control subjects in 
the present study.  After adjusting for confounding 
factors,  conditional logistic regression analysis 
showed that serum leptin levels were signiﬁcantly 
associated with hypertension in Japanese men.  Thus,  
leptin may be an independent predictor of hyperten-
sion.
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